Page 77 - Abt News Today

McKinley Carter Wealth Services Inc. trimmed its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 17.9% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 8,778 shares of the healthcare product maker’s stock after selling 1,909 shares during the quarter. McKinley Carter […]

Coldstream Capital Management Inc. cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% during the second quarter, HoldingsChannel reports. The firm owned 57,791 shares of the healthcare product maker’s stock after selling 1,119 shares during the period. Coldstream Capital Management Inc.’s holdings in Abbott Laboratories were worth $6,300,000 as of its most […]

Arcblock (ABT) traded up 10% against the dollar during the 1 day period ending at 10:00 AM E.T. on October 25th. One Arcblock token can currently be purchased for about $0.0737 or 0.00000214 BTC on major cryptocurrency exchanges. Arcblock has a total market capitalization of $7.27 million and approximately $163,622.33 worth of Arcblock was traded […]

By Sabela Ojea Abbott Laboratories said it has received positive results from its chronic limb-threatening ischemia trial and it expects to submit the drug...

Gables Capital Management Inc. raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 5.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,695 shares of the healthcare product maker’s stock after purchasing an additional 150 shares during […]

Forsta AP Fonden reduced its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 472,500 shares of the healthcare product maker’s stock after selling 1,300 shares during the quarter. Abbott […]

Accredited Investors Inc. lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 12.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,734 shares of the healthcare product maker’s stock after selling 1,654 shares during the quarter. Accredited Investors […]

It's been a tough year for the sector.

Blue Chip Partners LLC raised its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 148,855 shares of the healthcare product maker’s stock after buying an additional 4,931 shares during the […]

FFT Wealth Management LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,488 shares of the healthcare product maker’s stock after selling 287 shares during the quarter. FFT Wealth […]